Hot spot-driven discovery of β-catenin/Tcf4 interaction inhibitors via virtual drug repurposing study and experimental validation in colorectal cancer cells.
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.